Can you buy Synchron stock?

As Synchron is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company likeSynchron, you must be an accredited investor . If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Synchron stock?

To invest in a private company like Synchron through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process . 1. Create a free account to access Forge’s marketplace. 2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies. 3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Synchron stock?

Yes, you may be able to sell your Synchron stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Synchron stock?

If you hold private company shares of Synchron - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Synchron stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Synchron a public company?

No, Synchron is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Synchron’s stock price?

Synchron is a privately held company and therefore does not have a public stock price. However, you may access Synchron’s private market stock price with Forge Data .

What is Synchron’s stock ticker symbol?

Synchron does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Invest and Sell Synchron Stock

CNBC 07/16/2024

Brain implant patient says OpenAI’s tech helps him communicate with family

Synchron is using OpenAI's technology for its brain implant technology.

Business Wire 04/08/2024

Synchron Launches Patient Registry for Stentrode Brain Computer Interface

The brain-computer interface technology company Synchron launched a community center for a BCI device to help patients with neurological conditions without the need for invasive brain surgery.

Medical Device Network 03/21/2023

Synchron to start patient enrolment in brain-computer interface study

Synchron, an endovascular brain-computer interface (BCI) firm, has begun patient enrolment for its COMMAND study. The study will assess the safety and efficacy of the Synchron Switch, a BCI device that helps people with limited mobility operate technology using their thoughts. The device is implanted using a minimally-invasive procedure and the study will evaluate its impact on daily tasks such as texting, emailing, and online shopping.

NPR 03/17/2023

Tom Oxley: translating thoughts into text with brain implants

Tom Oxley, a physician and entrepreneur, is developing an implantable brain-computer interface at his company, Synchron. The technology allows a patient's thoughts to be transmitted wirelessly through the skin to control digital devices. Oxley is a neurointerventionist at Mount Sinai Hospital and has performed over 1,600 endovascular neurosurgical procedures.

Synchron Stock

Register To Buy and Sell Shares

Enterprise Value

Access Synchron’s valuation and stock price.

Synchron investors also invested in these private companies

Team

Management Team

Board Members

Synchron stock FAQs